BioCentury
ARTICLE | Company News

Ondine deal

July 4, 2011 7:00 AM UTC

Ondine's CEO and Chairman Carolyn Cross will acquire the company for C$0.33 per share, or C$3.2 million ($3.2 million). The price is a 65% premium to Ondine's close of C$0.20 on June 28, before the de...